• The Retina Pipeline

    The Future of Retina and the Latest Data

    Read Issue
  • The Great Fluid Debate

    Reviewing Treatment Outcome Goals for the Wet AMD Patient

    Read Article
  • A New Vision in Retinal Gene Therapy:

    From Clinical Trials to Clinical Practice

    Read Supplement
  • Ranibizumab—Retinal Care for All Ages:

    RIVAL (nAMD) to RAINBOW (ROP)

    Read Supplement
  •  
     
  • Retina Pipeline
  • Diabetic Retinopathy
  • Retinal Disease Awareness News
  • DME Disease Education Resource Center
  • Uveitis Resource Center
  • ZEISS OCT Angiography eNewsletter Series
  • Business Matters
  • AMD Disease Education Resource Center
  • diabetes awareness month
  • wet age-related macular degeneration month
  • Articles From This Issue

     

    UP FRONT

    Medical Editors’ Page

    The Future of Retina

    Retina specialists are charged with a difficult task. They must provide high quality care for patients in their clinics while simultaneously keeping track of the therapeutic…

    Retina News

    FDA Approves First Anti-VEGF Agent With Up to 3-Month Treatment Interval The US FDA in October approved brolucizumab (Beovu, Novartis) for the treatment of wet age-related…

    VISUALLY SPEAKING

    Optic Disc Melanocytoma

    A 32-year-old woman visited our clinic for a routine eye exam. Her BCVA was 20/20 near vision in both eyes. Anterior segment examination was unremarkable. Her right eye showed …

     

    Supplements and Inserts

    Insert

    The Great Fluid Debate

    Supplement

    A New Vision in Retinal Gene Therapy: From Clinical Trials to Clinical Practice

    NEWS


     

    Featured Content


    Contact Info

    Bryn Mawr Communications LLC
    1008 Upper Gulph Road, Suite 200
    Wayne, PA 19087

    Phone: 484-581-1800
    Fax: 484-581-1818

    Scott Krzywonos
    Editor-in-Chief
    484-581-1880
    skrzywonos@bmctoday.com

    Janet Burk
    Publisher
    214-394-3551
    jburk@bmctoday.com

    About Retina Today

    Retina Today is a publication that delivers the latest research and clinical developments from areas such as medical retina, retinal surgery, vitreous, diabetes, retinal imaging, posterior segment oncology and ocular trauma. Each issue provides insight from well-respected specialists on cutting-edge therapies and surgical techniques that are currently in use and on the horizon.